133 related articles for article (PubMed ID: 32012314)
21. The effects of yohimbine on the pharmacokinetic parameters of detomidine in the horse.
Knych HK; Steffey EP; Stanley SD
Vet Anaesth Analg; 2012 May; 39(3):221-9. PubMed ID: 22405129
[TBL] [Abstract][Full Text] [Related]
22. Characterisation of the in vivo interactions between detomidine and methadone in horses: Pharmacokinetic and pharmacodynamic modelling.
Gozalo-Marcilla M; Luna SPL; Moreira da Silva R; Crosignani N; Lopes NP; Taylor PM; Pelligand L
Equine Vet J; 2019 Jul; 51(4):517-529. PubMed ID: 30298682
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of butorphanol in horses after intramuscular injection.
Sellon DC; Papich MG; Palmer L; Remund B
J Vet Pharmacol Ther; 2009 Feb; 32(1):62-5. PubMed ID: 19161457
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and adverse effects of butorphanol administered by single intravenous injection or continuous intravenous infusion in horses.
Sellon DC; Monroe VL; Roberts MC; Papich MG
Am J Vet Res; 2001 Feb; 62(2):183-9. PubMed ID: 11212025
[TBL] [Abstract][Full Text] [Related]
25. A possible solution to model nonlinearity in elimination and distributional clearances with α
Gozalo-Marcilla M; Moreira da Silva R; Pacca Loureiro Luna S; Rodrigues de Oliveira A; Werneck Fonseca M; Peporine Lopes N; Taylor PM; Pelligand L
J Vet Pharmacol Ther; 2019 Nov; 42(6):738-744. PubMed ID: 31584710
[TBL] [Abstract][Full Text] [Related]
26. The effects of xylazine, detomidine, acepromazine and butorphanol on equine solid phase gastric emptying rate.
Sutton DG; Preston T; Christley RM; Cohen ND; Love S; Roussel AJ
Equine Vet J; 2002 Jul; 34(5):486-92. PubMed ID: 12358052
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of detomidine-butorphanol-guaifenesin-ketamine as short term TIVA in Spiti ponies.
Thakur BP; Sharma SK; Sharma A; Kumar A
Pak J Biol Sci; 2011 Jun; 14(11):647-52. PubMed ID: 22235506
[TBL] [Abstract][Full Text] [Related]
28. Preliminary study of the effects of xylazine or detomidine with or without butorphanol for standing sedation in dairy cattle.
Lin HC; Riddell MG
Vet Ther; 2003; 4(3):285-91. PubMed ID: 15136990
[TBL] [Abstract][Full Text] [Related]
29. Effects of treatment with oxytocin, xylazine butorphanol, guaifenesin, acepromazine, and detomidine on esophageal manometric pressure in conscious horses.
Wooldridge AA; Eades SC; Hosgood GL; Moore RM
Am J Vet Res; 2002 Dec; 63(12):1738-44. PubMed ID: 12492291
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the effects of commonly used α
Moorman VJ; Bass L; King MR
Am J Vet Res; 2019 Sep; 80(9):868-877. PubMed ID: 31449445
[TBL] [Abstract][Full Text] [Related]
31. DETOMIDINE AND BUTORPHANOL FOR STANDING SEDATION IN A RANGE OF ZOO-KEPT UNGULATE SPECIES.
Bouts T; Dodds J; Berry K; Arif A; Taylor P; Routh A; Gasthuys F
J Zoo Wildl Med; 2017 Sep; 48(3):616-626. PubMed ID: 28920785
[TBL] [Abstract][Full Text] [Related]
32. Detomidine and the combination of detomidine and MK-467, a peripheral alpha-2 adrenoceptor antagonist, as premedication in horses anaesthetized with isoflurane.
Pakkanen SA; Raekallio MR; Mykkänen AK; Salla KM; de Vries A; Vuorilehto L; Scheinin M; Vainio OM
Vet Anaesth Analg; 2015 Sep; 42(5):527-36. PubMed ID: 25529045
[TBL] [Abstract][Full Text] [Related]
33. The pharmacokinetics of butorphanol and its metabolites at steady state following nasal administration in humans.
Vachharajani NN; Shyu WC; Greene DS; Barbhaiya RH
Biopharm Drug Dispos; 1997 Apr; 18(3):191-202. PubMed ID: 9113342
[TBL] [Abstract][Full Text] [Related]
34. Comparison of two sedation protocols for long electroretinography in horses using the Koijman electrode.
Ignacio C; Del Mar LM; Marta B; Sina Z; Vicent R; Aloma MF
BMC Vet Res; 2023 Aug; 19(1):106. PubMed ID: 37537621
[TBL] [Abstract][Full Text] [Related]
35. Behavioural and cardiovascular effects of medetomidine constant rate infusion compared with detomidine for standing sedation in horses.
Hollis AR; Pascal M; Van Dijk J; Jolliffe C; Kaartinen J
Vet Anaesth Analg; 2020 Jan; 47(1):76-81. PubMed ID: 31619335
[TBL] [Abstract][Full Text] [Related]
36. Parenteral exposure to detomidine and butorphanol.
Reid FM; Tracey JA
J Toxicol Clin Toxicol; 1994; 32(4):465-9. PubMed ID: 8057408
[TBL] [Abstract][Full Text] [Related]
37. Sedative effects and pharmacokinetics of detomidine when administered intravenously and intravaginally as a gel in alpacas.
Chow NS; Seddighi R; Knych HK; Sun X; Doherty TJ
Vet Anaesth Analg; 2020 Nov; 47(6):773-780. PubMed ID: 32863105
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of butorphanol after intravenous, intramuscular, and oral administration in Hispaniolan Amazon parrots (Amazona ventralis).
Guzman DS; Flammer K; Paul-Murphy JR; Barker SA; Tully TN
J Avian Med Surg; 2011 Sep; 25(3):185-91. PubMed ID: 22216718
[TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetics of butorphanol following intramuscular administration to exercised thoroughbred horses.
Knych HK; Weiner D; McKemie DS; Traynham M; Blea J
J Vet Pharmacol Ther; 2024 Apr; ():. PubMed ID: 38687131
[TBL] [Abstract][Full Text] [Related]
40. Bioavailability of detomidine administered sublingually to horses as an oromucosal gel.
Kaukinen H; Aspegrén J; Hyyppä S; Tamm L; Salonen JS
J Vet Pharmacol Ther; 2011 Feb; 34(1):76-81. PubMed ID: 21219348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
